NCT00654160 Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer Status COMPLETED Phase PHASE1
NCT00648102 Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer Status COMPLETED Phase PHASE1
NCT00647530 Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery Status UNKNOWN Phase PHASE2/PHASE3
NCT00647153 Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00642603 A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00642577 A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE3
NCT00641615 Peptide Vaccine and S-1/CPT-11 Therapy for Patients With Unresectable Advanced Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00640471 Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00640081 Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00630786 Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study Status COMPLETED Phase PHASE1/PHASE2
NCT00630045 Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis Status UNKNOWN Phase PHASE3
NCT00628810 Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00628368 Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer Status COMPLETED Phase NA
NCT00626054 Comparison of Two Methods of Administration of a PEG Solution Status COMPLETED Phase PHASE4
NCT00625651 Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00625625 Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT00625573 Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01) Status COMPLETED Phase PHASE2
NCT00625183 Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma Status TERMINATED Phase PHASE2